Outcomes of adjuvant oral versus intravenous fluoropyrimidines for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

Jiaqiang Zhang, Yu Chun Yen, Lei Qin, Chia Lun Chang, Kevin Sheng Po Yuan, Alexander T.H. Wu, Szu Yuan Wu

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Outcomes of adjuvant oral versus intravenous fluoropyrimidines for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences